对女性高血压人类心脏的多组学研究
Zachary J Milstone1, Jesse D Moreira-Bouchard1,2, Karan K Smith1
1Evans Department of Medicine and The Whitaker Cardiovascular Institute, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Physiological reports
|October 2, 2025
概括
高血压会改变心脏分子通路,包括DNA修复和新陈代谢,并影响成人心脏中的细胞群. 这项研究提供了关于高血压分子特征的关键人类数据.
科学领域:
- 心血管生物学 心血管生物学
- 分子心脏病学分子心脏病学
- 人类病理学 人类病理学
背景情况:
- 高血压是心脏病的主要危险因素,影响全球数百万人.
- 现有的知识严重依赖于动物模型,缺乏人类心血管组织的洞察力.
- 之前的工作建立了一个保护死后人类心脏研究的协议.
研究的目的:
- 为了研究与高血压相关的成年人心脏中的分子变化.
- 为了利用死后心脏组织的多组学分析.
- 建立研究人类心血管疾病的基础.
主要方法:
- 试点多组分析 (散装RNA-seq,单核RNA-seq,代谢学) 在死后的人类心脏.
- 从有高血压 (n=3) 和没有高血压 (n=2) 的捐赠者的心脏进行比较.
- 系统地剖析和保存整个人类的心脏.
主要成果:
- 高血压与DNA螺旋酶活性,NAD依赖性脱乙酶活性和分支链氨基酸代谢的转录增加有关.
- 单核RNA-seq揭示了收缩性血管光滑肌细胞的丧失以及高血压心脏中内皮细胞增殖的增加.
- 代谢药物表明减少压力和改变代谢途径,包括脂肪酸氧化和酸路径.
结论:
- 对死后人类心脏的多组学分析是心血管疾病研究的可行方法.
- 在成人心脏组织中发现高血压的分子特征,包括细胞和代谢变化.
- 提供了对高血压对心脏影响的新基于人类的分子见解.
相关概念视频
Hypertension II: Pathophysiology
795
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
795
Hypertension III: Clinical Manifestations and Diagnostic Studies
471
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
471
Hormonal Regulation of Blood Pressure
5.9K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
5.9K
Hypertension and Regulation of Blood Pressure
3.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
800
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
800
Cardiomyopathy III: Hypertrophic Cardiomyopathy
411
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
411


